Discover trends, market shifts, and competitive outlooks for the mumps vaccine (mumpsvax) global market report 2025 industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Mumps Vaccine (MumpsVax) Market Through 2034?

In recent times, the mumps vaccine (mumpsvax) sector has significantly expanded, projecting a growth from $2,057.93 million in 2024 to $2,210.59 million in 2025, yielding a compound annual growth rate (CAGR) of 7.4%. Such growth during the historic period can be associated with factors like an increase in child vaccine rates, rise in global health initiatives, a growth in public reliance on vaccines, improved travel awareness, and an upsurge in immunization drives.

Anticipated robust augmentation is seen in the mumps vaccine (mumpsvax) market size in the forthcoming years. Projected to inflate to $2,902.21 million by 2029, it carries a compound annual growth rate (CAGR) of 7.0%. This upswing during the prophesied period can be associated with escalating cases of diseases that can be prevented through vaccination, heightened awareness about adult vaccination, increasing health-conscious populace, expansion of immunization programs, and growth of global health initiatives. Key trends in the predicted timeline encompass personalized immunization tactics, incorporation of digital health, improved surveillance systems, research and development in the realm of adult vaccination, and integration of artificial intelligence in the field.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Mumps Vaccine (MumpsVax) Market?

The increased occurrence of infectious diseases is projected to drive the growth of the mumps vaccine (mumpsvax) market. These diseases are triggered by harmful microorganisms like viruses, bacteria, fungi, or parasites that can spread from person to person or via polluted surroundings. The factors contributing to this increase include urbanization, climate change, globalization, altered human demographics, and behaviors that enable the outbreak of pathogens. Mumpsvax, a vaccine for mumps, is primarily utilized to thwart mumps infection, a disease spread by the mumps virus. Typically, it is part of the MMR (measles, mumps, rubella) immunization. For example, a report by the UK Health Security Agency in August 2024 revealed that in 2023, the West Midlands region reported the most measles cases, counting for 160 cases (44%), followed by London with 122 cases (33%). Importantly children under 10 constituted 63% of the total cases, equivalent to 232 cases. As the year ended there was a substantial spike in measles activity, recording 157 new cases in December as opposed to just 45 cases in November. Consequently, the escalating prevalence of infectious diseases bolsters the mumps vaccine (mumpsvax) market. A surge in healthcare expenditure is projected to drive the mumps vaccine (mumpsvax) market by promoting access to Mumpsvax and boosting immunization rates. This expenditure encompasses the total amount spent on healthcare items and services including personal care, preventive services and public health measures, all with the aim to improve health outcomes within a specific timeframe. The driving forces behind the increasing healthcare expenditure include an aging populace, chronic illnesses, sophisticated medical equipment, high drug prices, ineffective payment systems, and an augmented demand for services. This rising expenditure influences the mumps vaccine (mumpsvax) market by fortifying funding for vaccination initiatives, thus enhancing reach of the vaccine and subsequently promoting improved public health results through increased immunization coverage against mumps. For example, a report by the Office For National Statistics in May 2024 revealed that the total healthcare expenditure saw a 5.6% rise in nominal terms from 2022 to 2023 compared to a growth of 0.9% in 2022. Furthermore, overall long-term health and social expenditure saw an increase of 2.8% in real terms in 2022. As a result, this growth in healthcare expenditure plays a significant role in advancing the mumps vaccine (mumpsvax) market.

Which Key Market Segments Comprise the Mumps Vaccine (MumpsVax) Market and Drive Its Revenue Growth?

The mumps vaccine (mumpsvax)market covered in this report is segmented –

1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types

2) By Age Group: Pediatric; Adult

3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies

4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19909&type=smp

Which Areas Are Leading Regions in the Mumps Vaccine (MumpsVax) Market Expansion Across the Globe?

North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report

How Is the Mumps Vaccine (MumpsVax) Market Conceptually Defined?

Mumps vaccine (MumpsVax) is a live attenuated vaccine that prevents mumps using the Jeryl Lynn strain of the virus. Administered in two doses, it is often combined with the MMR (measles, mumps, rubella) vaccine and provides over 95% protection against mumps. Although standalone production has ceased, mumps vaccine (mumpsvax) remains crucial for public health efforts to reduce mumps outbreaks and has significantly lowered incidence rates in vaccinated populations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model